Abstract
Background
Several evidences indicate stimulation of peroxisome proliferator activated receptor γ (PPARg), promotes neuronal differentiation. This study was conducted to testify the prominence of PPARγ during neural differentiation of human embryonic stem cells (hESCs).
Methods
PPARγ expression level was assessed during neural differentiation of hESCs. Meanwhile, the level of endogenous miRNAs, which could be engaged in regulation of PPARγ expression, was measured. Next, natural and synthetic components of PPARγ agonists and antagonist were implemented on neural progenitor formation during neural differentiation of hESCs.
Results
Data showed an increasing wave of PPARγ expression level when human neural progenitors (NPs) were formed upon retinoic acid treatment. Interestingly, there was no significant difference in the amount of PPARγ proteins during the differentiation of hESCs that is inconsistent with what we observed for RNA level. Our results indicated that miRNAs are not involved in the regulation of PPARγ expression, while proteasome-mediated degradation may to some degree be involved in this process. Among numerous treatments, PPARγ inactivation during NPs formation significantly decreased expression of NP markers.
Conclusions
We conclude that a ground state of PPARγ activity is required for NP formation of hESCs during early neural differentiation. However, high expression and activity of PPARγ could not enhance the required neural differentiation, whereas the PPARγ inactivation could negatively influence NP formation from hESCs by antagonist.
Similar content being viewed by others
References
Blumberg B, Evans RM. Orphan nuclear receptors new ligands and new possibilities. Genes Dev 1998;12:3149–55.
Escher P, Wahli W. PPARs: insight into multiple cellular functions. Mutat Res 2000;488:121–38.
Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000;405:421–4.
Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for PPARγ. J Biol Chem 1995;270:12953–56.
Miglio G, Rattazzi L, Rosa AC, Fantozzi R. PPARγ stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells. Neurosci Lett 2009;454:134–8.
Wright HM, Clish CB, Mikami T, Hauser S, Yanagi K, Hiramatsu R, et al. A synthetic antagonist for the PPARγ inhibits adipocyte differentiation. J Biol Chem 2000;275:1873–7.
Perez-Ortiz JM, Tranque P, Vaquero CF, Domingo B, Molina F, Calvo S, et al. Glitazones differentially regulate primary astrocyte and glioma cell survival involvement of ROS and PPARγ. J Biol Chem 2004;279:8976–85.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. ESC lines derived from human blastocysts. Science 1998;282:1145–7.
Dhara SK, Stice SL. Neural differentiation of hESCs. J Cell Biochem 2008;105: 633–40.
Denham M, Dottori M. Signals involved in neural differentiation of hESCs. Neurosignals 2009;17:234–41.
Rosen ED, Spiegelman BM. PPARγ/a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001;276:37731–34.
Lehrke M, Lazar MA. The many faces of PPARγ. Cell 2005;123:993–9.
Tsai YS, Maeda N. PPARγ: a critical determinant of body fat distribution in humans and mice. Trends Cardiovasc Med 2005;5:81–5.
Wada K, Nakajima A, Katayama K, Kudo C, Shibuya A, Kubota N, et al. PPARγ-mediated regulation of NSC proliferation and differentiation. J Biol Chem 2006;281:12673–81.
Mo C, Chearwae W, Bright JJ. PPARγ regulates LIF-induced growth and self-renewal of mESCs through Tyk2-Stat3 pathway. Cell Signal 2009;22(3): 495–500.
Cristiano L, Bernardo A, Ceru MP. PPARs and peroxisomes in rat cortical and cerebellar astrocytes. J Neurocytol 2001;30:671–83.
Woods JW, Tanen M, Figueroa DJ, Biswas C, Zycband E, Moller DE, et al. Localization of PPARγ in murine CNS: expression in oligodendrocytes and neurons. Brain Res 2003;975:10–21.
Moreno S, Farioli-Vecchioli S, Ceru MP. Immunolocalization of PPARs and RXRs in the adult rat CNS. Neuroscience 2004;123:131–45.
Park KS, Lee RD, Kang SK, Han SY, Park KL, Yang KH, et al. Neuronal differentiation of embryonic midbrain cells by upregulation of PPARγ via the JNK-dependent pathway. Exp Cell Res 2004;297:424–33.
Satoh T, Furutam K, Tomokiyomm K, Nakatsuka D, Tanikawa M, Nakanishi M, et al. Facilitatory roles of novel compounds designed from cyclopentenone prostaglandins on neurite outgrowth-promoting activities of NGF. J Neurochem 2000;75:1092–102.
Han SW, Greene ME, Pitts J, Wada RK, Sidell N. Novel expression and function of PPARγ in human neuroblastoma cells. Clin Cancer Res 2001;7(1):98–104.
Jung KM, Park KS, Oh JH, Jung SY, Yang KH, Song YS, et al. Activation of p38 MAPK and activator protein-1 during the promotion of neurite extension of 15d-PGJ2. Mol Pharmacol 2003;63(3):607–16.
Morales-Garcia JA, Luna-Medina R, Alfaro-Cervello C, Cortes-Canteli M, Santos A, Garcia-Verdugo JM, et al. PPARγ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo. Glia 2011;59:293–307.
Kanakasabai S, Pestereva E, Chearwae W, Gupta SK, Ansari S, Bright JJ. PPARγ agonists promote oligodendrocyte differentiation of NSCs by modulating stemness and differentiation genes. PLoS ONE 2012;7(11).
Ghoochani A, Shabani K, Peymani M, Ghaedi K, Karamali F, Karbalaei K, et al. The influence of PPARγ1 during differentiation of mESCs to neural cells. Differentiation 2012;83:60–7.
Baharvand H, Mehrjardi Z, Hatami M, Kiani S, Rao M, Haghighi MR. Neural differentiation from hESCs in a defined adherent culture condition. Int J Dev Biol 2007;51:371–8.
Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. BFGF and suppression of BMP signaling sustain undifferentiated proliferation of hESCs. Nat Methods 2005;2:185–90.
Bugge A, Grøntved L, Aagaard M, Borup R, Mandrup S. The PPARγ2 A/B-domain plays a gene-specific role in transactivation and cofactor recruitment. Mol Endocrinol 2009;23:794–808.
Collino M, Patel N, Lawrence K, Collin M, Latchman D, Yaqoob M, et al. The selective PPARγ antagonist GW9662 reverses the protection of LPS in a model of renal ischemia–reperfusion. Kidney Int 2005;68:529–36.
Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, et al. Functional consequences of cysteine modification in the ligand binding sites of PPARs by GW9662. Biochemistry 2002;41:6640–50.
Sundberg M, Savola S, Hienola A, Korhonen L, Lindholm D. Glucocorticoid hormones decrease proliferation of embryonic NSCs through ubiquitin-mediated degradation of cyclin D1. J Neurosci 2006;26(20):5402–10.
Rohwedel J, Guan K, Wobus AM. Induction of cellular differentiation by RA in vitro. Cells Tissues Organs 1999;165:190–202.
Glaser T, Brüstle O. RA induction of ESC derived neurons: the radial glia connection. Trends Neurosci 2005;28:397–400.
Maden M. RA in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 2007;8:755–65.
Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, et al. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expression. Biochem Biophys Res Commun 2010;392(3):323–8.
Karbiener M, Fischer C, Nowitsch S, Opriessnig P, Papak C, Ailhaud G, et al. miR-27b impairs human adipocyte differentiation and targets PPARγ. Biochem Biophys Res Commun 2009;390(2):247–51.
Zhang JF, Fu WM, He ML, **e WD, Lv Q, Wan G, et al. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol 2011;8(5):829–38.
Lee EK, Lee MJ, Abdelmohsen K, Kim W, Kim MM, Srikantan S, et al. miR-130 suppresses adipogenesis by inhibiting PPARγ expression. Mol Cell Biol 2011;31(4):626–38.
Desvergne B, Wahli W. PPARs: nuclear control of metabolism. Endocr Rev 1999;20:649–88.
Baharvand H, Fathi A, Gourabi H, Mollamohammadi S, Salekdeh GH. Identification of mESC-associated proteins. J Proteome Res 2008;7(1):412–23.
Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15d-PGJ2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995;83:803–12.
Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, et al. Sequential treatment of SH-SY5Y cells with retinoic acid and BDNF gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 2000;75:991–1003.
Cai C, Grabel L. Directing the differentiation of ESCs to NSCs. Dev Dyn 2007;236:3255–66.
Chen L, Chen Y, Zhang S, Ye L, Cui J, Sun Q, et al. ATMiR-540 as a novel adipogenic inhibitor impairs adipogenesis via suppression of PPARγ. J Cell Biochem 2015;116(6):969–76.
Sun L, Goff LA, Trapnell C, Alexander R, Lo KA, Hacisuleyman E, et al. Long noncoding RNAs regulate adipogenesis. Proc Natl Acad Sci USA 2013;110(9): 3387–92.
Ma X, Yang P, Kaplan WH, Lee BH, Wu LE, Yang JY, et al. ISL1 regulates peroxisome proliferator-activated receptor γ activation and early adipogenesis via bone morphogenetic protein 4-dependent and -independent mechanisms. Mol Cell Biol 2014;34(19):3607–17.
Xu B, Gerin I, Miao H, Vu-Phan D, Johnson CN, Xu R, et al. Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. PLoS ONE 2010;5(12):14199.
Li N, Kelsh RN, Croucher P, Roehl HH. Regulation of neural crest cell fate by the retinoic acid and PPARγ signalling pathways. Development 2010;137(3): 389–94.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Taheri, M., Salamian, A., Ghaedi, K. et al. A ground state of PPARγ activity and expression is required for appropriate neural differentiation of hESCs. Pharmacol. Rep 67, 1103–1114 (2015). https://doi.org/10.1016/j.pharep.2015.04.011
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.pharep.2015.04.011